XBiotech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +22.2% | -31.9% | -50.1% | -8.0% | -6.7% | -0.1% | -0.4% | -88.9% | +206.0% | +9.8% | -82.1% | -100.0% | – | – | – | +0.0% | -100.0% | – | – | – | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +36.5% | -28.6% | -76.2% | +2.5% | -41.0% | -18.4% | -5.8% | -79.6% | -2.8% | +3.9% | -92.6% | +2,668.8% | -1.8% | -0.7% | +0.5% | +0.0% | +0.2% | +0.9% | – | – | -0.7% | -2.7% | -11.5% | -12.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -23.6% | -51.1% | +169.0% | -15.7% | +24.3% | +7.7% | +1.3% | -91.7% | +361.0% | +10.7% | -80.6% | -256.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -40.2% | -9.6% | -33.4% | +19.8% | 0.0% | -49.3% | +31.9% | -0.2% | +22.9% | -6.5% | +3.7% | -3.4% | +128.0% | -88.8% | +122.1% | -8.5% | +47.5% | +33.9% | +99.7% | -39.5% | +56.8% | -22.4% | +52.4% | -32.5% | +4.3% | -14.9% | +80.8% | -33.0% | +3.4% | +25.9% | +32.2% | -45.1% | +9.7% | +48.6% | -54.1% | -4.8% | +399.2% | -79.5% | +1.7% | – | |
| – | -24.4% | +9.9% | -27.3% | -3.8% | +0.0% | -27.7% | +44.5% | -29.7% | +7.7% | +1.0% | +2.7% | +20.2% | +88.5% | +35.3% | +55.3% | -44.8% | +30.0% | -67.3% | +208.3% | -65.9% | +21.1% | -29.6% | +130.1% | -72.2% | +34.4% | -19.0% | +117.7% | -51.2% | -19.5% | +31.3% | +92.8% | -60.8% | +19.3% | +108.3% | -48.2% | -3.3% | +354.7% | -75.7% | -20.4% | – | |
| – | -37.5% | -5.7% | -31.9% | +13.9% | 0.0% | -44.7% | +35.4% | -9.0% | +19.4% | -5.0% | +3.5% | +1.7% | +117.8% | -61.1% | +70.2% | -34.3% | +37.1% | -23.2% | +125.8% | -48.1% | +49.1% | -23.6% | +65.0% | -41.5% | +7.5% | -15.4% | +85.6% | -35.7% | -4.3% | +33.1% | +37.9% | -47.2% | +10.7% | +54.9% | -53.2% | -4.6% | +392.1% | -80.0% | +3.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +138.6% | +1,505.0% | +23.3% | -31.0% | – | – | – | +0.0% | -93.9% | +1.5% | +0.5% | -56.9% | -100.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -290.1% | – | – | – | – | – | -122.4% | – | +871.4% | -325.0% | – | +127,653.8% | -100.7% | – | – | – | – | – | – | – | – | – | – | -75.9% | -106.4% | – | +333.8% | -132.1% | – | -200.0% | – | -555.6% | – | -3.4% | +264.3% | -25.5% | -35.5% | -6.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.